Revefenacin

Overview

Revefenacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3833319).

API suppliers (6)

Suppliers of Revefenacin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• Cipla USA, Inc.USA1 active DMF
• INKE SASpain1 active DMF
• Mankind Pharma LimitedIndia1 active DMF
• MEDICHEM MANUFACTURING (MALTA) LTDMalta1 active DMF
• MSN Laboratories Private LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Revefenacin expires 23 Oct 2039. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate

Canonical SMILES

CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N

InChIKey

FYDWDCIFZSGNBU-UHFFFAOYSA-N